Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6113633 | Critical Reviews in Oncology/Hematology | 2014 | 17 Pages |
Abstract
The rationale for adding chemotherapy to radiotherapy remains to be demonstrated prospectively. Although the type of systemic treatments used may be adapted on histology, the strongest rationale remains in favor of cisplatin.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Thomas Cerda, Xu Shan Sun, Stéphane Vignot, Pierre-Yves Marcy, Bertrand Baujat, Anne-Catherine Baglin, Ali Mohamed Ali, Sylvie Testelin, Emile Reyt, Francois Janot, Juliette Thariat,